Nanjing Medlander Medical Technology Co Ltd
SSE:688273
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Nanjing Medlander Medical Technology Co Ltd
Capital Expenditures
Nanjing Medlander Medical Technology Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Nanjing Medlander Medical Technology Co Ltd
SSE:688273
|
Capital Expenditures
-¥129.7m
|
CAGR 3-Years
-107%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Capital Expenditures
-¥285.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Capital Expenditures
-¥166.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Capital Expenditures
-¥2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Capital Expenditures
-¥268.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-18%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Capital Expenditures
-¥1.9B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Nanjing Medlander Medical Technology Co Ltd
Glance View
Nanjing Medlander Medical Technology Co., Ltd. engages in the research, development, production, and sale of pelvic floor rehabilitation products. The company is headquartered in Nanjing, Jiangsu and currently employs 511 full-time employees. The company went IPO on 2022-08-11. The firm's products mainly include pelvic floor and postpartum rehabilitation equipment, consumables and accessories, information products and others, including biostimulation feedback instruments, basin training instruments, basin biostimulation feedback instruments, vaginal electrodes, pelvic maintenance instruments and others. The firm's products are mainly used in obstetrics and gynecology, gynecology, pelvic floor rehabilitation centers, confinement centers, postpartum rehabilitation centers, mother and child centers and other professional institutions in medical institutions.
See Also
What is Nanjing Medlander Medical Technology Co Ltd's Capital Expenditures?
Capital Expenditures
-129.7m
CNY
Based on the financial report for Dec 31, 2024, Nanjing Medlander Medical Technology Co Ltd's Capital Expenditures amounts to -129.7m CNY.
What is Nanjing Medlander Medical Technology Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-23%
Over the last year, the Capital Expenditures growth was -73%. The average annual Capital Expenditures growth rates for Nanjing Medlander Medical Technology Co Ltd have been -107% over the past three years , -23% over the past five years .
